跳至主要内容
临床试验/CTRI/2016/11/007423
CTRI/2016/11/007423已完成4 期

The efficacy of Trospium for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study

Apollo Hospitals Bilaspur Chhattisgarh India1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年1月8日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Incidence and severity of catheter related bladder discomfort

研究概览

简要总结

Postoperative urinary catheter related bladder discomfort (CRBD) can occasionally occur in patients who have undergone catheterization during surgery. Trospium is a non selective muscarinic receptor antagonist. It has been effective in prevention Over active bladder symptoms. As these symptoms are similar to catheter related discomfort, this drug may have beneficial role in CRBD.

All selected patients will be randomized into 2 groups (30 in each group) depending on the drug given -

Group T - Patients will be received Trospium 60 mg orally 1 hr before the inducion of anesthesia

Group C - Patients will be received placebo 1 hr before the induction of anesthesia

Primary Outcome - Incidence and severity of catheter related bladder discomfort

Secondary Outcome - Any complication like PONV, facial flushing, dry mouth, blurred vision and abdominal discomfort

Statistical analysis will be done after completion of study

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Age group 20-60 years 2.ASA grade I and II, 3.Requiring urinary Cathetrization.

排除标准

  • 1.Patients with known sensitivity to study drug, 2.History of drug or alcohol abuse, 3.History of chronic pain or daily intake of analgesics, 4.Pregnant or breast-feeding females, 5.Uncontrolled medical disease (diabetes mellitus and hypertension) 6.Impaired kidney or liver functions and 7.Psychiatric patients.

结局指标

主要结局

Incidence and severity of catheter related bladder discomfort

时间窗: On arrival in the post anesthesia care unit(0 hr) and again at 1, 2, and 6 hr later

次要结局

  • Any complication like postoperative nausea vomiting, facial flushing, dry mouth, blurred vision and abdominal discomfort(During postoperative period)

研究者

发起方
Apollo Hospitals Bilaspur Chhattisgarh India
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验